$CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Healthcare
Sector
Biotechnology
Industry
Alison Moore
CEO
188
Employees
$1.25
Current Price
$116.52M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $17,238.80 | 12,670 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $17,238.80 | 12,670 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $17,238.80 | 12,670 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $17,238.80 | 12,670 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Erbez Georgia Chief Financial Officer and Chief Business Officer | Sale | 6,335 | $1.36 | $8,619.40 | View Details |
| Oct 12, 2026 | MOORE ALISON Director | Sale | 6,335 | $1.36 | $8,619.40 | View Details |
20 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.09
ActualN/A
Revenue
Estimated$18.73M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$SNVW โ SANUWAVE Health, Inc.via Opaleye Management Inc.$GRCE โ Grace Therapeutics, Inc.via Opaleye Management Inc.$ACOG โ Alpha Cognition Inc.via Opaleye Management Inc.$SLGL โ Sol-Gel Technologies Ltd.via Opaleye Management Inc.$ETON โ Eton Pharmaceuticals, Inc.via Opaleye Management Inc.